Dr. Anthony Fauci to give likely final Covid briefing as top White House health official

Dr. Anthony Fauci to give likely final Covid briefing as top White House health official


NIH National Institute of Allergy and Infectious Diseases Director Anthony Fauci addresses the daily press briefing at the White House in Washington, January 21, 2021.

Jonathan Ernst | Reuters

Dr. Anthony Fauci on Tuesday will give what is expected to be his last public briefing on the Covid-19 pandemic as the White House chief medical advisor.

Fauci announced earlier this year that he will step down in December after serving as the public face of the United States’ coronavirus pandemic response for more than two years.

He will give an update alongside Dr. Ashish Jha, head of the White House Covid task force. They are expected to encourage people to get their Covid boosters and flu shots as soon as possible.

Public health officials have repeatedly warned that the U.S. will likely face another wave of Covid this winter as people travel and gather for the holidays.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The new boosters, which target the variant omicron BA.5, were quickly rolled out in an effort to head off a major surge. But only about 11% of those people eligible have received their shot so far.

The U.S. already facing a severe flu season, with hospitalizations at a decade high.

And respiratory syncytial virus, or RSV, is also hospitalizing children at a much higher rate than in pre-pandemic seasons.

Hospitals and emergency departments are increasingly taxed by people seeking treatment for respiratory illnesses.

Children’s hospitals last week called on the Biden administration to declare a public health emergency to provide more flexibility to address the surge of patients.



Source

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Health

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients at a more than 40% discount. The move comes as the Trump administration ramps up pressure on the pharmaceutical industry to cut drug prices, and threatens to impose sweeping tariffs on pharmaceuticals imported into the […]

Read More
Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise
Health

Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise

Boxes of tablets, produced by Novartis AG, sit on a pharmacy counter. Bloomberg | Bloomberg | Getty Images Swiss pharmaceutical firm Novartis said Thursday that it expects its Kisqali breast cancer treatment to be the next blockbuster drug within its portfolio, as it looks to shift reliance away from its Entresto heart failure therapy. Sales of Kisqali, […]

Read More
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Health

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

Cr | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Another potential competitor to blockbuster obesity treatments from Eli Lilly and Novo Nordisk just showed positive data – but this time, […]

Read More